Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases, ...

He directed lead discovery at Tularik, a biopharmaceutical company purchased by Amgen in 2004 for $2.5 billion ... San Francisco (UCSF), an M.S. degree from the University of Missouri, Columbia ...

UCSF Health has announced a major step forward in advancing the integration of UCSF Benioff Children’s Hospital Oakland and UCSF Health’s systems, infrastructure, and workforce. On July 1, 2025, all ...

Investors with a lot of money to spend have taken a bearish stance on Amgen AMGN. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

The latest trading session saw Amgen (AMGN) ending at $267.10, denoting a -1.14% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 0.12% for the ...

At the time, UCSF colleagues and I were concerned that TCE exposure increased Parkinson’s risk, but there wasn’t enough scientific data to support a definitive determination. That’s why we wanted to ...

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Amgen's market standing. Stay informed and make well-considered decisions with our ...

An official ribbon-cutting ceremony took place Friday for Amgen's new manufacturing plant in Holly Springs. It's at the CaMP Helix Innovation Park. The celebration also included a ground-breaking ...

Thousand Oaks, CA-based Amgen is one of the biggest biotech companies in the world, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation ...

A dozen wake Technical Community College students signed letters of intent on Monday to work with Amgen. Amgen is planning a $1 billion expansion in Holly Springs. “This is a really good ...